Linezolid for the treatment of resistant gram-positive cocci (Q34247278)

31 July 2017

1 reference

title

Linezolid for the treatment of resistant gram-positive cocci (English)

1 reference

31 July 2017

gram-positive bacteria

0 references

1 reference

K T Bain

1

1 reference

PubMed ID

11346064

31 July 2017

E T Wittbrodt

series ordinal

2

1 reference

PubMed ID

11346064

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Annals of Pharmacotherapy

31 July 2017

1 reference

31 July 2017

35

1 reference

31 July 2017

5

1 reference

31 July 2017

566-575

1 reference

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

31 July 2017

1 reference

Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci

21 January 2018

1 reference

The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals

21 January 2018

1 reference

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

21 January 2018

1 reference

Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program

21 January 2018

1 reference

Vancomycin-resistant enterococcal infections

21 January 2018

1 reference

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen.

21 January 2018

1 reference

The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

21 January 2018

1 reference

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.

21 January 2018

1 reference

The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.

21 January 2018

1 reference

Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145.

21 January 2018

1 reference

Staphylococcus aureus: a well-armed pathogen

21 January 2018

1 reference

The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.

21 January 2018

1 reference

Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia

21 January 2018

1 reference

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

21 January 2018

1 reference

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound

21 January 2018

1 reference

In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones

21 January 2018

1 reference

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

21 January 2018

1 reference

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

21 January 2018

1 reference

The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis

21 January 2018

1 reference

Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin

21 January 2018

1 reference

Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).

21 January 2018

1 reference

Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.10276

1 reference

31 July 2017

1 reference

PubMed ID

11346064